De Novo Status Epilepticus in patients with COVID‐19

Autor: Shruti P. Agnihotri, Tyler E. Gaston, Sandipan Pati, Alissa Chitlangia, Sana Somani
Jazyk: angličtina
Rok vydání: 2020
Předmět:
0301 basic medicine
Pediatrics
medicine.medical_specialty
Levetiracetam
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Pneumonia
Viral

Clinical Neurology
Neurosciences. Biological psychiatry. Neuropsychiatry
Status epilepticus
Brief Communication
Asymptomatic
03 medical and health sciences
Betacoronavirus
0302 clinical medicine
Status Epilepticus
medicine
Humans
In patient
RC346-429
Pandemics
Subclinical infection
Aged
Retrospective Studies
business.industry
SARS-CoV-2
General Neuroscience
COVID-19
Retrospective cohort study
Electroencephalography
Middle Aged
medicine.disease
Black or African American
Pneumonia
030104 developmental biology
Anticonvulsants
Female
Neurology (clinical)
Neurology. Diseases of the nervous system
medicine.symptom
business
Coronavirus Infections
030217 neurology & neurosurgery
RC321-571
Zdroj: Annals of Clinical and Translational Neurology
Annals of Clinical and Translational Neurology, Vol 7, Iss 7, Pp 1240-1244 (2020)
ISSN: 2328-9503
DOI: 10.1002/acn3.51071
Popis: Neurological complications are increasingly recognized with SARS‐CoV‐2, the causative pathogen for COVID‐19. We present a single‐center retrospective case series reporting the EEG and outcome of de novo status epilepticus (SE) in two African‐American women with laboratory‐confirmed SARS‐CoV‐2 virus. SE was the initial presentation in one asymptomatic individual. Patient 2 had COVID‐19 pneumonia, and fluctuating mental status that raised the suspicion of subclinical SE. The patient with older age and higher comorbidities failed to recover from the viral illness that has no definitive treatment.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje